Ascendis Pharma (ASND) PT Lowered to $160 at Evercore ISI, 'hard to ignore this new risk'
Tweet Send to a Friend
(Updated - March 6, 2023 8:47 AM EST)
Evercore ISI analyst Josh Schimmer lowered the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Josh Schimmer lowered the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
